Shares of Westlake Corporation (NYSE:WLK – Get Free Report) have been given an average recommendation of “Hold” by the seventeen brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year ...

Core Insights - The success of Berkshire Hathaway (BRK.B) is attributed to its disciplined capital allocation strategy, which focuses on investing only when risk-adjusted returns are favorable, thereby compounding shareholder wealth while minimizing the risk of permanent capital loss [1][4] Group 1: Capital Allocation Strategy - Berkshire Hathaway's disciplined approach is evident in its acquisition of OxyChem and Bell Laboratories in 2025, which enhances its operational portfolio by generating stable cash flow and offering long-term growth potential [2][8] - The company maintains significant cash and U.S. Treasury holdings exceeding $370 billion and a float of $176 billion, which supports its prudent capital allocation strategy [3][8] - Berkshire repurchases shares only when they are undervalued, which increases shareholder value by enhancing ownership stakes in its high-quality business portfolio [3] Group 2: Performance and Valuation - Year-to-date, BRK.B shares have decreased by 1.7%, although this performance is better than the industry average [7] - The price-to-book value ratio for BRK.B is 1.47, which is above the industry average of 1.38, indicating a relatively expensive valuation [10] - The Zacks Consensus Estimate for BRK.B's first-quarter 2026 EPS has increased by 0.8% over the last 30 days, while estimates for 2026 and 2027 EPS have decreased by 0.8% each [11][12]

Core Insights - Westlake Corporation (WLK) reported a significant net loss of $544 million or $4.22 per share for Q4 2025, contrasting with a profit of $7 million or 6 cents per share in the same quarter of the previous year. The adjusted loss per share was 25 cents, which was better than the Zacks Consensus Estimate of a loss of $1.44 [1][9]. Financial Performance - Sales decreased by approximately 10.9% year over year to $2,533 million in Q4 2025, falling short of the Zacks Consensus Estimate of $2,567.4 million. This decline was attributed to lower average sales prices and reduced sales volume [2]. - The fourth quarter results were adversely affected by increased feedstock and energy costs, as well as the shutdown of three chlorovinyl production facilities and one styrene facility in North America, leading to noncash accelerated depreciation and asset write-off charges [3]. Segment Performance - The Performance and Essential Materials (PEM) segment experienced a sales decline of around 12.4% year over year to $1,632 million, missing the estimate of $1,652 million. The segment reported a loss from operations of $717 million, a significant increase from a loss of $41 million in Q4 2024, primarily due to lower selling prices and reduced sales volume of key products [4]. - The Housing and Infrastructure Products (HIP) segment generated sales of $901 million, down about 8.1% from the previous year, also missing the estimate of $1,008 million. The income from operations in this segment fell to $66 million, down $129 million from Q4 2024, driven by lower sales volume and margins [5]. Financial Position - Operating activities generated $225 million in net cash during Q4 2025, while capital expenditures were $241 million, resulting in a free cash outflow of $16 million. As of December 31, 2025, the company had approximately $2.7 billion in cash and cash equivalents, with long-term debt amounting to $5.1 billion [6]. Future Outlook - Westlake anticipates an improvement in profitability for 2026, despite ongoing challenges from weak global industrial and manufacturing activity. The company is implementing cost-cutting measures and aims to enhance PEM profitability to achieve a targeted $600 million in EBITDA improvement. Additionally, the HIP segment is expected to benefit from the acquisition of ACI in January 2026 [7].

4Q25 & FY25 Earnings Call J a n u a r y 3 0 , 2 0 2 6 Forward-looking Statements 1 Value-first commercial approach continues to preserve ECU values 2 Announced Braskem long-term agreement, upgrading our export EDC values 3 Successful Epoxy volume growth amid European capacity closures 4 Winchester reduced commercial production accelerating destocking 5 Generated $321M of operating cash flow, keeping net debt flat year-over-year Chlor Alkali Products & Vinyls Segment Performance This presentation includes fo ...

Core Insights - Olin Corporation reported a net loss of $85.7 million for Q4 2025, a significant decline from a net income of $10.7 million in Q4 2024, reflecting ongoing market challenges and operational disruptions [1][2] - The company's adjusted EBITDA for Q4 2025 was $67.7 million, down from $193.4 million in Q4 2024, indicating a substantial decrease in operational profitability [1][27] - Total sales for Q4 2025 were $1,665.1 million, slightly lower than $1,671.3 million in Q4 2024, showing a stable revenue stream despite adverse conditions [1][21] Financial Performance - The full year 2025 reported a net loss of $42.8 million, compared to a net income of $108.6 million in 2024, highlighting a year-over-year decline in profitability [1][21] - Operating cash flow for Q4 2025 was $321.2 million, demonstrating effective cash generation despite the net loss [2] - The company ended 2025 with net debt of approximately $2.7 billion, maintaining a net debt to adjusted EBITDA ratio of 4.1 times, indicating a stable leverage position [12][32] Segment Performance - Chlor Alkali Products and Vinyls segment reported sales of $856.4 million in Q4 2025, down from $953.7 million in Q4 2024, primarily due to lower pricing [6][7] - The Epoxy segment saw sales increase to $359.3 million in Q4 2025 from $282.2 million in Q4 2024, driven by higher volumes, although it still reported a segment loss of $19.2 million [8] - Winchester segment sales were $449.4 million in Q4 2025, up from $435.4 million in Q4 2024, with military sales offsetting declines in commercial ammunition [9] Strategic Initiatives - The company is focused on its "Optimize the Core" strategic priorities, which include enhancing operational reliability and achieving structural cost reductions through the Beyond250 initiative, which has already realized $44 million in cost savings in 2025 [2][3] - Olin plans to close its epoxy resin manufacturing facility in Guarujá, Brazil, in Q1 2026, expecting to achieve annual structural cost savings of approximately $10 million [11] - The company anticipates that its Epoxy business will return to profitability in 2026, supported by new supply agreements and ongoing cost reduction efforts [3]

Published: January 2026 1 FISCAL 2026 Q3 INVESTOR PRESENTATION FORWARD-LOOKING STATEMENTS © 2026 Hawkins, Inc. The information contained in this presentation includes "forward-looking statements" which reflect management's expectations or beliefs as of the date of this presentation. Hawkins, Inc. cautions that actual future results could differ materially from the forward-looking statements in this presentation. Actual results may be affected by many important factors including risks and uncertainties ident ...

Core Insights - Warren Buffett will retire at age 95 after over 60 years of running Berkshire Hathaway, making a significant investment in OxyChem for $9.7 billion just before his departure [1][2] Group 1: Acquisition Details - Berkshire Hathaway is acquiring OxyChem, a petrochemicals business from Occidental Petroleum, marking its most significant acquisition since 2022 [2] - The acquisition price of $9.7 billion is considered a bargain, with OxyChem being valued at about eight times its projected 2025 EBITDA, especially in a weak chemical industry [3] - OxyChem is a stable cash generator producing essential products like chlorine, caustic soda, and PVC, which are crucial for various industries [4] Group 2: Financial Implications - The structure of the deal benefits both companies, with Occidental Petroleum receiving $9.7 billion in cash, planning to use $6.5 billion to reduce its debt below $15 billion, thus improving its balance sheet [5] - This debt reduction is expected to save Occidental $350 million to $400 million annually in interest payments, enhancing Berkshire's existing 28.2% ownership and providing additional protection against energy price volatility [5]

Core Viewpoint - Olin Corporation has revised its fourth quarter 2025 adjusted EBITDA outlook to approximately $67 million, significantly lower than the previous estimate of $110 to $130 million, primarily due to issues in the Chlor Alkali Products and Vinyls business [1][2]. Company Overview - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products, including chlorine, caustic soda, vinyls, and various other chemicals, as well as a major U.S. manufacturer of ammunition [3]. Financial Performance - The adjusted EBITDA for the fourth quarter 2025 is now expected to be around $67 million, a decrease from the earlier forecast of $110 to $130 million [1]. - The earnings shortfall is attributed to an extended planned maintenance turnaround and unplanned downtime at the Freeport, Texas operations, along with lower-than-expected pipeline chlorine demand [1][2]. Operational Challenges - The Chlor Alkali Products and Vinyls segment faced a significant decline in chlorine demand and operational issues at the Freeport site, which included a planned turnaround and interruptions in raw material supply from a third party [2]. - The Freeport site has since returned to normal operations, but the impact of these challenges has affected the overall financial outlook [2].

Core Insights - Olin Corporation's shares have faced significant challenges, with a 48.69% decline over the past year, attributed to factors such as subsidized imports from Asia and Europe [4][9] - Teresa M. Vermillion, the VP & Treasurer, sold 4,500 shares through an option exercise, resulting in a 20.74% reduction in her direct ownership [7][9] - The company is focusing on its core chemical and ammunition segments, with a recent strategic partnership with Braskem aimed at enhancing growth in its vinyls business [10][11] Company Overview - Olin Corporation operates in the chemicals and ammunition sectors, generating revenue of $6.8 billion and a net income of $53.80 million [4][5] - The company has a dividend yield of 3.9% and has seen a 1-year price change of -48.69% [4] Transaction Details - The transaction involved the sale of shares at a weighted average price of approximately $20.86, with a total transaction value of around $93,850.20 [2][7] - Post-transaction, Vermillion holds 17,199 shares, valued at approximately $353,783.43 [2][7] Market Context - The company's stock performance has been negatively impacted by subdued global demand in the epoxy market and lower-than-expected ammunition sales [10] - The recent insider transaction is viewed as administrative rather than indicative of the company's future performance [7][9]

Core Insights - Warren Buffett will step down as CEO of Berkshire Hathaway on January 1, 2026, while remaining as chairman, with Greg Abel set to succeed him [1] - Buffett executed a $9.7 billion deal to acquire OxyChem from Occidental Petroleum shortly before the leadership transition [1][2] Company Background - Berkshire Hathaway has a long-standing relationship with Occidental Petroleum, having provided a $10 billion loan in 2019 for its acquisition of Anadarko Petroleum [4] - Berkshire has been increasing its stake in Occidental, currently owning 26.9% of the company, valued at approximately $11.7 billion [5][6] Acquisition Details - The $9.7 billion purchase price for OxyChem is significant compared to Occidental's market cap of $43.6 billion [6] - OxyChem is involved in producing chemicals for various applications, including chlorine and polyvinyl chloride, and plays a role in Occidental's carbon capture initiatives [7] Strategic Implications - The acquisition aligns with Berkshire Hathaway's investment strategy, focusing on underappreciated businesses rather than high-growth stocks [8] - The sale of OxyChem is not expected to hinder Occidental's low-carbon goals but indicates a shift towards projects that generate immediate free cash flow [9]